585 related articles for article (PubMed ID: 1522221)
1. Human bactericidal/permeability-increasing protein and a recombinant NH2-terminal fragment cause killing of serum-resistant gram-negative bacteria in whole blood and inhibit tumor necrosis factor release induced by the bacteria.
Weiss J; Elsbach P; Shu C; Castillo J; Grinna L; Horwitz A; Theofan G
J Clin Invest; 1992 Sep; 90(3):1122-30. PubMed ID: 1522221
[TBL] [Abstract][Full Text] [Related]
2. Endotoxin-neutralizing properties of the 25 kD N-terminal fragment and a newly isolated 30 kD C-terminal fragment of the 55-60 kD bactericidal/permeability-increasing protein of human neutrophils.
Ooi CE; Weiss J; Doerfler ME; Elsbach P
J Exp Med; 1991 Sep; 174(3):649-55. PubMed ID: 1875165
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of neonatal innate defense: effects of adding an N-terminal recombinant fragment of bactericidal/permeability-increasing protein on growth and tumor necrosis factor-inducing activity of gram-negative bacteria tested in neonatal cord blood ex vivo.
Levy O; Sisson RB; Kenyon J; Eichenwald E; Macone AB; Goldmann D
Infect Immun; 2000 Sep; 68(9):5120-5. PubMed ID: 10948134
[TBL] [Abstract][Full Text] [Related]
4. Effect of lipopolysaccharide (LPS) chain length on interactions of bactericidal/permeability-increasing protein and its bioactive 23-kilodalton NH2-terminal fragment with isolated LPS and intact Proteus mirabilis and Escherichia coli.
Capodici C; Chen S; Sidorczyk Z; Elsbach P; Weiss J
Infect Immun; 1994 Jan; 62(1):259-65. PubMed ID: 8262637
[TBL] [Abstract][Full Text] [Related]
5. The bactericidal/permeability increasing protein of neutrophils is a potent antibacterial and anti-endotoxin agent in vitro and in vivo.
Elsbach P; Weiss J; Doerfler M; Shu C; Kohn F; Ammons WS; Kung AH; Meszaros KK; Parent JB
Prog Clin Biol Res; 1994; 388():41-51. PubMed ID: 7831373
[TBL] [Abstract][Full Text] [Related]
6. The bactericidal/permeability-increasing protein (BPI), a potent element in host-defense against gram-negative bacteria and lipopolysaccharide.
Elsbach P; Weiss J
Immunobiology; 1993 Apr; 187(3-5):417-29. PubMed ID: 8330906
[TBL] [Abstract][Full Text] [Related]
7. A novel endotoxin antagonist attenuates tumor necrosis factor-alpha secretion.
Dahlberg PS; Acton RD; Battafarano RJ; Uknis ME; Ratz CA; Johnston JW; Haseman JR; Gray BH; Dunn DL
J Surg Res; 1996 Jun; 63(1):44-8. PubMed ID: 8661170
[TBL] [Abstract][Full Text] [Related]
8. A peptide derived from human bactericidal/permeability-increasing protein (BPI) exerts bactericidal activity against Gram-negative bacterial isolates obtained from clinical cases of bovine mastitis.
Chockalingam A; McKinney CE; Rinaldi M; Zarlenga DS; Bannerman DD
Vet Microbiol; 2007 Nov; 125(1-2):80-90. PubMed ID: 17560054
[TBL] [Abstract][Full Text] [Related]
9. Bactericidal permeability-increasing protein in host defence against gram-negative bacteria and endotoxin.
Elsbach P
Ciba Found Symp; 1994; 186():176-87; discussion 187-9. PubMed ID: 7768151
[TBL] [Abstract][Full Text] [Related]
10. Antibacterial proteins of granulocytes differ in interaction with endotoxin. Comparison of bactericidal/permeability-increasing protein, p15s, and defensins.
Levy O; Ooi CE; Elsbach P; Doerfler ME; Lehrer RI; Weiss J
J Immunol; 1995 May; 154(10):5403-10. PubMed ID: 7730641
[TBL] [Abstract][Full Text] [Related]
11. Structural and functional organization of the human neutrophil 60 kDa bactericidal/permeability-increasing protein.
Ooi CE; Weiss J; Elsbach P
Agents Actions; 1991 Sep; 34(1-2):274-7. PubMed ID: 1793043
[TBL] [Abstract][Full Text] [Related]
12. Peptide derivatives of three distinct lipopolysaccharide binding proteins inhibit lipopolysaccharide-induced tumor necrosis factor-alpha secretion in vitro.
Battafaraono RJ; Dahlberg PS; Ratz CA; Johnston JW; Gray BH; Haseman JR; Mayo KH; Dunn DL
Surgery; 1995 Aug; 118(2):318-24. PubMed ID: 7638748
[TBL] [Abstract][Full Text] [Related]
13. Competition between rBPI23, a recombinant fragment of bactericidal/permeability-increasing protein, and lipopolysaccharide (LPS)-binding protein for binding to LPS and gram-negative bacteria.
Gazzano-Santoro H; Mészáros K; Birr C; Carroll SF; Theofan G; Horwitz AH; Lim E; Aberle S; Kasler H; Parent JB
Infect Immun; 1994 Apr; 62(4):1185-91. PubMed ID: 8132325
[TBL] [Abstract][Full Text] [Related]
14. A recombinant amino terminal fragment of bactericidal/permeability-increasing protein inhibits the induction of leukocyte responses by LPS.
Mészáros K; Parent JB; Gazzano-Santoro H; Little R; Horwitz A; Parsons T; Theofan G; Grinna L; Weickmann J; Elsbach P
J Leukoc Biol; 1993 Dec; 54(6):558-63. PubMed ID: 8245707
[TBL] [Abstract][Full Text] [Related]
15. Sensitivity of K1-encapsulated Escherichia coli to killing by the bactericidal/permeability-increasing protein of rabbit and human neutrophils.
Weiss J; Victor M; Cross AS; Elsbach P
Infect Immun; 1982 Dec; 38(3):1149-53. PubMed ID: 6759406
[TBL] [Abstract][Full Text] [Related]
16. Impaired innate immunity in the newborn: newborn neutrophils are deficient in bactericidal/permeability-increasing protein.
Levy O; Martin S; Eichenwald E; Ganz T; Valore E; Carroll SF; Lee K; Goldmann D; Thorne GM
Pediatrics; 1999 Dec; 104(6):1327-33. PubMed ID: 10585984
[TBL] [Abstract][Full Text] [Related]
17. The role of bactericidal/permeability-increasing protein as a natural inhibitor of bacterial endotoxin.
Marra MN; Wilde CG; Collins MS; Snable JL; Thornton MB; Scott RW
J Immunol; 1992 Jan; 148(2):532-7. PubMed ID: 1729370
[TBL] [Abstract][Full Text] [Related]
18. Bactericidal/permeability-increasing protein has endotoxin-neutralizing activity.
Marra MN; Wilde CG; Griffith JE; Snable JL; Scott RW
J Immunol; 1990 Jan; 144(2):662-6. PubMed ID: 2295804
[TBL] [Abstract][Full Text] [Related]
19. Role of endotoxin in acute inflammation induced by gram-negative bacteria: specific inhibition of lipopolysaccharide-mediated responses with an amino-terminal fragment of bactericidal/permeability-increasing protein.
Kohn FR; Kung AH
Infect Immun; 1995 Jan; 63(1):333-9. PubMed ID: 7806373
[TBL] [Abstract][Full Text] [Related]
20. A 25-kDa NH2-terminal fragment carries all the antibacterial activities of the human neutrophil 60-kDa bactericidal/permeability-increasing protein.
Ooi CE; Weiss J; Elsbach P; Frangione B; Mannion B
J Biol Chem; 1987 Nov; 262(31):14891-4. PubMed ID: 3667613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
